Search Results - "Debourdeau, Philippe"

International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer by Farge, Dominique, Prof, Bounameaux, Henri, Prof, Brenner, Benjamin, Prof, Cajfinger, Francis, MD, Debourdeau, Philippe, MD, Khorana, Alok A, Prof, Pabinger, Ingrid, Prof, Solymoss, Susan, MD, Douketis, James, Prof, Kakkar, Ajay, Prof

“…Summary Venous thromboembolism (VTE) is the second leading cause of death in patients with cancer. These patients are at an increased risk of developing VTE…”
Get full text

A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy‐Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy by Zelek, Laurent, Debourdeau, Philippe, Bourgeois, Hugues, Wagner, Jean Philippe, Brocard, Fabien, Lefeuvre‐Plesse, Claudia, Chauffert, Bruno, Leheurteur, Marianne, Bachet, Jean‐Baptiste, Simon, Hélène, Mayeur, Didier, Scotté, Florian

“…Background Neurokinin (NK) 1 receptor antagonists (RAs), administered in combination with a 5‐hydroxytryptamine‐3 (5‐HT3) RA and dexamethasone (DEX), have…”
Get full text

Role of supportive care in improving the quality of life and reducing unscheduled hospital care in patients with metastatic breast cancer by Arnaud, Antoine, Grenier, Julien, Boustany, Rania, Kirscher, Sylvie, Mege, Alice, de Rauglaudre, Gaëtan, Vazquez, Léa, Debourdeau, Philippe

“…Background Metastatic breast cancer (MBC) patients experience long survival and report poorer quality of life than localized breast cancer patients…”
Get full text

Venous Thromboembolism Prophylaxis and Treatment in Cancer: A Consensus Statement of Major Guidelines Panels and Call to Action by Khorana, Alok A, Streiff, Michael B, Farge, Dominique, Mandala, Mario, Debourdeau, Philippe, Cajfinger, Francis, Marty, Michel, Falanga, Anna, Lyman, Gary H

“…Venous thromboembolism (VTE) is an increasingly frequent complication of cancer and its treatments, and is associated with worsened mortality and morbidity in…”
Get full text

Management and Research in Cancer Treatment-Related Cardiovascular Toxicity: Challenges and Perspectives by Cautela, Jennifer, Lalevee, Nathalie, Ammar, Chloé, Ederhy, Stéphane, Peyrol, Michael, Debourdeau, Philippe, Serin, Daniel, Le Dolley, Yvan, Michel, Nicolas, Orabona, Morgane, Barraud, Jérémie, Laine, Marc, Bonello, Laurent, Paganelli, Franck, Barlési, Fabrice, Thuny, Franck

“…Abstract Cardiovascular toxicity is a potentially serious complication that can result from the use of various cancer therapies and can impact the short- and…”
Get full text

Impact of venous thromboembolism on the natural history of pancreatic adenocarcinoma by Ouaïssi, Mehdi, Frasconi, Cécilia, Mege, Diane, Panicot-dubois, Laurence, Boiron, Laurence, Dahan, Laetitia, Debourdeau, Philippe, Dubois, Christophe, Farge, Dominique, Sielezneff, Igor

“…Few studies have analyzed the effect of ve- nous thromboembolism （VTE） events on the prognosis of pancreatic cancer, but their results were conflicting. The…”
Get full text

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial by Charton, Emilie, Bachet, Jean‐Baptiste, Hammel, Pascal, Desramé, Jérôme, Chibaudel, Benoist, Cohen, Romain, Debourdeau, Philippe, Dauba, Jérome, Lecomte, Thierry, Seitz, Jean‐François, Tournigand, Christophe, Aparicio, Thomas, Guerin‐Meyer, Véronique, Taieb, Julien, Volet, Julien, Louvet, Christophe, Anota, Amélie, Bonnetain, Franck

“…Background The phase II AFUGEM GERCOR trial aimed to assess the efficacy of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine (gemcitabine…”
Get full text

Implementing thrombosis guidelines in cancer patients: a review by Farge-Bancel, Dominique, Bounameaux, Henri, Brenner, Benjamin, Büller, Harry R, Kakkar, Ajay, Pabinger, Ingrid, Streiff, Michael, Debourdeau, Philippe

“…Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and…”
Get full text

Which events to consider in the study of venous thromboses in pancreatic cancer patients? by Debourdeau, Philippe, Launay, Simon, Chaouche, Malika

Get full text

Venous thromboembolism associated with central venous catheters in patients with cancer: From pathophysiology to thromboprophylaxis, areas for future studies by Debourdeau, Philippe, Lamblin, Anne, Debourdeau, Théodore, Marcy, Pierre Yves, Vazquez, Léa

“…Symptomatic catheter related thrombosis (CRT) occurs in 4%–8% of cancer patients. The mean incidence of CRT, detected either by echography or Doppler ranges…”
Get full text

Do we need to treat asymptomatic catheter-related thrombosis? by Debourdeau, Philippe, Hugret, Jean Philippe, Debourdeau, Théodore

Get full text

Involvement of Platelet-Derived Microparticles in Tumor Progression and Thrombosis by Mezouar, Soraya, Mege, Diane, Darbousset, Roxane, Farge, Dominique, Debourdeau, Philippe, Dignat-George, Françoise, Panicot-Dubois, Laurence, Dubois, Christophe

“…Platelet-derived microparticles (PMPs) represent the most abundant microparticle (MP) subtype. Their presence reflects platelet activity, physiopathology, and…”
Get full text

Patients treated with palbociclib and endocrine therapy for metastatic breast cancer: Can we predict the occurrence of severe early hematological toxicity? by Vazquez, Léa, Arnaud, Antoine, Grenier, Julien, Debourdeau, Philippe

“…The addition of palbociclib to endocrine therapy has been shown to improve progression free survival in hormone receptor positive metastatic breast cancer…”
Get more information

Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors by Alma, Stancu, Eloi, Debourdeau, Léa, Vazquez, Julie, Coussirou, Valérie, Matagne, Pierre, Grassi, Hilgers, Werner, Philippe, Girard, Christine, Zammit, Philippe, Debourdeau

“…Venous-thromboembolism (VTE) is increased in lung cancer patients (LCP) treated with immune-checkpoint inhibitors (ICIs) but risk factors are not identified…”
Get full text

Central venous catheter associated upper extremity deep vein thrombosis in cancer patients: Diagnosis and therapeutic management by Elias, Antoine, Debourdeau, Philippe, Espitia, Olivier, Sevestre, Marie-Antoinette, Girard, Philippe, Mahé, Isabelle, Sanchez, Olivier

“…Catheter-related thrombosis (CRT) is a relatively frequent and potentially fatal complication arising in patients with cancer who require a central catheter…”
Get full text

Treatment of cancer-associated venous thromboembolism in patients under palliative care by Debourdeau, Philippe, Sevestre, Marie-Antoinette, Bertoletti, Laurent, Mayeur, Didier, Girard, Philippe, Scotté, Florian, Sanchez, Olivier, Mahé, Isabelle

“…Many patients with cancer require palliative care at some stage and the vast majority of people followed in palliative care are cancer patients. Patients with…”
Get full text

Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry by Borjas Howard, Jaime, Ruiz‐Sada, Pablo, de Leeuw, Karina, López‐Jiménez, Luciano, Font, Carme, Marchena, Pablo Javier, Madridano, Olga, Debourdeau, Philippe, Meijer, Karina, Monreal, Manuel

“…Summary Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with…”
Get full text

Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short‐term prognosis by Schulman, S., Zondag, M., Linkins, L., Pasca, S., Cheung, Y. W., Sancho, M., Gallus, A., Lecumberri, R., Molnar, S., Ageno, W., Le Gal, G., Falanga, A., Hulegårdh, E., Ranta, S., Kamphuisen, P., Debourdeau, P., Rigamonti, V., Ortel, T. L., Lee, A.

“…Summary Background Recommendations for management of cancer‐related venous thromboembolism (VTE) in patients already receiving anticoagulant therapy are based…”
Get full text

Life-threatening eosinophilic pleuropericardial effusion related to vitamins B5 and H by Debourdeau, PM, Djezzar, S, Estival, JL, Zammit, CM, Richard, RC, Castot, AC

“…OBJECTIVE: To report a case of eosinophilic pleuropericarditis resulting from concomitant use of vitamins B5 and H. CASE SUMMARY: A 76-year-old white woman was…”
Get full text

Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019? by Debourdeau, Philippe, Cossou-Gbeto, Cresent, Takam-Sohwe, Thierry, Laroche, Jean-Pierre

“…According to international clinical practice guidelines, low-molecular-weight heparins are advocate for the treatment and the prevention of cancer associated…”
Get more information